#### POLITICAL SPENDING AND LOBBYING
Avanos does not currently operate a political action committee (PAC) in the United States or elsewhere. Similarly, the company makes no contributions to political candidates, PACs that contribute to candidates, or other organizations formed solely for the election or defeat of a public official in the United States or elsewhere.
Avanos is a member of AdvaMed, a medical device industry association, which lobbies on behalf of its members. In 2024, Avanos participated in federal lobbying activities in the United States to help alleviate the opioid crisis through the NOPAIN Act. We engaged the firms ADVI and Polsinelli to advise and represent the company on Medicare coverage and payment policy issues tied to the opioid issue before the Centers for Medicare and Medicaid Services (CMS).
Avanos also actively engaged in advocacy efforts, collaborating with Polsinelli, to address the unexpected mid-year announcement of a 50%–100% tariff on syringes and needles manufactured in China. As a result of these efforts, an extension was granted for ENFit syringes — primarily serving neonatal and pediatric patients — delaying the tariff's effective date from Q4 2024 to January 2026.